A new advanced glycation inhibitor, LR-90, prevents experimental diabetic retinopathy in rats


Autoria(s): Bhatwadekar, Ashay; Glenn, Josephine; Figarola, J.L.; Scott, Sharon; Gardiner, Tom; Rahbar, S.; Stitt, Alan
Data(s)

01/04/2008

Resumo

Background: Diabetic retinopathy is associated with accumulation of advanced glycation end products in the retinal microvasculature. LR-90 is an effective multistage inhibitor of advanced glycation with renoprotective and anti-inflammatory properties.

Identificador

http://pure.qub.ac.uk/portal/en/publications/a-new-advanced-glycation-inhibitor-lr90-prevents-experimental-diabetic-retinopathy-in-rats(9be249da-0cb5-402c-9f9f-ef0f9cb2c6ad).html

http://dx.doi.org/10.1136/bjo.2007.127910

http://www.scopus.com/inward/record.url?scp=41849131467&partnerID=8YFLogxK

Idioma(s)

eng

Direitos

info:eu-repo/semantics/restrictedAccess

Fonte

Bhatwadekar , A , Glenn , J , Figarola , J L , Scott , S , Gardiner , T , Rahbar , S & Stitt , A 2008 , ' A new advanced glycation inhibitor, LR-90, prevents experimental diabetic retinopathy in rats ' British Journal of Ophthalmology , vol 92 , no. 4 , pp. 545-547 . DOI: 10.1136/bjo.2007.127910

Palavras-Chave #/dk/atira/pure/subjectarea/asjc/2700/2731 #Ophthalmology
Tipo

article